Results 241 to 250 of about 25,303 (250)

Proprotein Convertase PCSK9

2013
openaire   +1 more source

Safety and efficacy of alirocumab 150 mg every 2 weeks, a fully human proprotein convertase subtilisin/kexin type 9 monoclonal antibody: A Phase II pooled analysis

Postgraduate Medicine, 2015
Eli M Roth, Daniel Gipe, Corinne Hanotin
exaly  

T-cell-expressed proprotein convertase FURIN inhibits DMBA/TPA-induced skin cancer development

OncoImmunology, 2016
Hennele Uusitalo-Jarvinen, Zuzet Martinez Córdova, Tero A H Järvinen   +2 more
exaly  

Proprotein Convertase PACE4

2013
openaire   +1 more source

Circulating proprotein convertase subtilisin-kexin type 9, all-cause mortality, and cardiovascular mortality: The Ludwigshafen Risk and Cardiovascular Health study

European Journal of Preventive Cardiology, 2017
Tatjana Stojakovic, Marcus E Kleber, Winfried März   +2 more
exaly  

Proprotein Convertase 4

2013
openaire   +1 more source

Proprotein convertase subtilisin/kexin type 9 (PCSK9): From structure–function relation to therapeutic inhibition

Nutrition, Metabolism and Cardiovascular Diseases, 2011
Giuseppe Danilo Norata, Alberico L. Catapano, G D Norata   +2 more
exaly  

Defective Neuropeptide Processing and Ischemic Brain Injury: A Study on Proprotein Convertase 2 and its Substrate Neuropeptide in Ischemic Brains

Journal of Cerebral Blood Flow and Metabolism, 2009
Shuqin Zhan, Giuseppe Pignataro, An Zhou
exaly  

Proprotein convertase subtilisin/kexin type 9 levels and aortic valve calcification: A prospective, cross sectional study

Journal of International Medical Research, 2016
exaly  

Proprotein Convertase 1/3

2013
openaire   +1 more source